View:
Download DOC
Download PDF
Download XLS
Lifevantage Corporation (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   June 9, 2009

Lifevantage Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

     
Colorado 000-30489 90-0224471
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
11545 W. Bernardo Court, Suite 301, San Diego, California   92127
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   858-312-8000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Chief Operating Officer

On June 16, 2009, Lifevantage Corporation (the "Company") announced that the Board of Directors of the Company has appointed Kirby Zenger as Chief Operating Officer of the Company effective June 9, 2009. The press release announcing the appointment is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Prior to joining the Company, Mr. Zenger most recently co-founded and served as Executive Vice President and General Manager of a network marketing nutrition company. Mr. Zenger has over ten years of experience in the direct sales and network marketing industry, and has served as a consultant to several of the industry leaders. In addition, Mr. Zenger has advised Fortune 1000 companies on the development of new markets and organizational structure.

Mr. Zenger will be entitled to an annual base salary of $215,000. Mr. Zenger was also granted an option to purchase 150,000 shares of the Company’s common stock on March 27, 20 09. The option has an exercise price of $0.70 per share, which was the closing price of the Company’s common stock as quoted on the OTC Bulletin Board on the date of grant. The option will vest in full on the date that is twelve months following the date of grant and is subject to the terms of the Company’s 2007 Long-Term Incentive Plan.

Change in Position for Chief Financial Officer

On June 16, 2009, the Company announced that Brad Amman resigned from the position of Chief Financial Officer of the Company effective June 9, 2009. Mr. Amman has been appointed VP of Finance for the Company and will also be involved with the Company’s international expansion program.





Item 7.01 Regulation FD Disclosure.

On June 16, 2009, the Company issued a press release entitled "Network Marketing Veteran Kirby Zenger Named COO of LifeVantage; Brad Amman Named to LifeVantage International Expansion Team." The press release is attached as Exhibit 99.1 hereto.





Item 9.01 Financial Statements and Exhibits.

d) Exhibits

Exhibit 99.1 Press Release, dated June 16, 2009, entitled "Network Marketing Veteran Kirby Zenger Named COO of LifeVantage; Brad Amman Named to LifeVantage International Expansion Team"





Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Lifevantage Corporation
          
June 16, 2009   By:   /s/ Bradford K. Amman
       
        Name: Bradford K. Amman
        Title: Secretary/Treasurer

Top of the Form

Exhibit Index


     
Exhibit No.   Description
 
99.1
  Press Release, dated June 16, 2009, entitled “Network Marketing Veteran Kirby Zenger Named COO of LifeVantage; Brad Amman Named to LifeVantage International Expansion Team”
EX-99.1

     
FOR IMMEDIATE RELEASE   NEWS
June 16, 2009
  OTCBB: LFVN

Contact: Jan Strode (619) 890-4040

or

Jean Golden

(612) 385-2324

Network Marketing Veteran Kirby Zenger Named COO of LifeVantage;
Brad Amman Named to LifeVantage International Expansion Team

SAN DIEGO, CA, June 16, 2009 – LifeVantage Corporation (OTCBB: LFVN), maker of Protandim®, today announced the appointment of Kirby Zenger to the role of Chief Operating Officer.

Mr. Zenger, who joined LifeVantage in February as Executive Vice President, has led a distinguished career in the network marketing sector. Prior to joining LifeVantage, he most recently co-founded and served as Executive Vice President and General Manager of a successful network marketing nutrition company, which achieved over 40 million in revenue in its first year of business. He has an extensive background in sales, sales organization, leadership development, and training. Mr. Zenger has over 10 years of experience in the direct sales and network marketing industry, and has served as a consultant to several of the industry leaders. In addition, Mr. Zenger has advised Fortune 1000 companies on the development of new markets and organizational structure.

“Kirby brings varied and invaluable experience from both the network marketing industry as well as traditional business,” said David W. Brown, President and CEO of LifeVantage Corporation. “He has a proven track record in building and growing network marketing sales organizations at an impressive rate. In all respects Kirby has brought momentum to the LifeVantage team and his leadership is a valuable asset.”

“It is an exciting opportunity to serve as the Chief Operating Officer of LifeVantage. Based upon my many years of experience in creating, building and operating successful network marketing organizations, I believe that LifeVantage has the potential to emerge as a true leader in the direct marketing channel. The science behind our product is unprecedented in the industry and the caliber of our management team is unmatched. That is why the Company is attracting the interest of so many distributors and why I believe we are ideally positioned to serve millions of consumers,” said Mr. Zenger.

The Company also announced that former CFO Brad Amman will be part of the LifeVantage team that is responsible for international expansion, including the launch into Mexico, slated for Fall 2009.

About LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based, natural products company, dedicated to helping people reach their health and wellness goals through science-based solutions to oxidative stress. Founded in 2003 and based in San Diego, CA, LifeVantage develops nutraceutical products, including Protandim®, that leverage the company’s expertise and that are intended to deliver significant health benefits to consumers. For more information, visit www.LifeVantage.com. 

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company uses the words “anticipate,” “believe,” “could,” “should,” “estimate,” “expect,” “intend,” “may,” “predict,” “project,” “plan,” “target” and similar terms and phrases, including references to assumptions, to identify forward-looking statements. These forward-looking statements are based on the Company’s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company’s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, the risk that government regulators and regulations could adversely affect our business; future laws or regulations may hinder or prohibit the production or sale of our existing product and any future products; unfavorable publicity could materially hurt our business; and the Company’s ability to protect our intellectual property rights and the value of our product. These and other risk factors are discussed in greater detail in the Company’s Annual Report on Form 10-KSB under the caption “Risk Factors”, and in other documents filed the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

###

Note to Editors: Contact Jan Strode at 619-890-4040 or Jean Golden 612-385-2324 for interviews, photography, and other requests.